The Technical Analyst
Select Language :
Nuwellis, Inc. [NUWE]

Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices

Nuwellis, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Nuwellis, Inc. is listed at the  Exchange

-9.73% US12542Q700.356

America/New_York / 28 mar 2024 @ 16:00


Nuwellis, Inc.: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 2.42 mill
EPS: -11.52
P/E: -0.0300
Earnings Date: May 06, 2024
SharesOutstanding: 6.80 mill
Avg Daily Volume: 0.870 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Sell
Return On Asset: Strong Sell
DE: Neutral
P/E: Neutral
Price To Book: Neutral
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.0300 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
0.00x
Company: PE -0.0300 | industry: PE 222.16
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

US12542Q70 0.279 - 0.433

( +/- 21.66%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-01-02 Mccormick Michael Kendrick Buy 20 836 Nonstatutory Stock Option (right to buy)
2024-01-02 Mcdonald David Buy 11 365 Nonstatutory Stock Option (right to buy)
2024-01-02 Feldshon Archelle Georgiou Buy 11 365 Nonstatutory Stock Option (right to buy)
2023-11-01 Mcdonald David Buy 0
2023-11-01 Feldshon Archelle Georgiou Buy 0
INSIDER POWER
98.00
Last 90 transactions
Buy: 3 285 386 | Sell: 12 287

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - US12542Q700.356
Forecast 2: 16:00 - US12542Q700.356
Forecast 3: 16:00 - US12542Q700.356
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price US12542Q700.356 (-9.73% )
Volume 0.413 mill
Avg. Vol. 0.870 mill
% of Avg. Vol 47.43 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Nuwellis, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Nuwellis, Inc.

RSI

Intraday RSI14 chart for Nuwellis, Inc.

Last 10 Buy & Sell Signals For NUWE

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Nuwellis, Inc.

NUWE

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Last 10 Buy Signals

Date Signal @
GTUSDMar 28 - 16:29$9.47
OMUSDMar 28 - 16:280.739
DESOUSDMar 28 - 16:2531.07
MPLUSDMar 28 - 16:2323.41
OCEANUSDMar 28 - 16:251.467
INVUSDMar 28 - 16:2457.37
LAZIOUSDMar 28 - 16:233.57
ZQUSDMar 28 - 16:1494.67
OETHUSDMar 28 - 16:183 549.35
SNBNBUSDMar 28 - 16:18582.79

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.